Showing results (401-410 of 414) with videos related to

Sort By:
Pageof 42
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 23, 2007
Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosisJ P Devogelaer, J P Brown, P Burckhardt, et al.
Bone|July 23, 2004
A meta-analysis of previous fracture and subsequent fracture riskJ A Kanis, O Johnell, C De Laet, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 2, 2005
Body mass index as a predictor of fracture risk: a meta-analysisC De Laet, J A Kanis, A Odén, et al.
Osteoarthritis and Cartilage|March 15, 2011
Application of biomarkers in the development of drugs intended for the treatment of osteoarthritisV B Kraus, B Burnett, J Coindreau, et al.
JAMA|October 12, 1999
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) InvestigatorsB Ettinger, D M Black, B H Mitlak, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 21, 2011
The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosisH M Zhu, L Qin, P Garnero, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 10, 2002
Is the predictive power of previous fractures for new spine and non-spine fractures associated with biochemical evidence of altered bone remodelling? The EPOS study. European Prospective Osteoporosis StudyP Vergnaud, M Lunt, C Scheidt-Nave, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 30, 2015
Vertebral Scheuermann's disease in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and overG Armbrecht, D Felsenberg, M Ganswindt, et al.
Arthritis and Rheumatism|February 24, 2001
Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trialJ D Adachi, K G Saag, P D Delmas, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 11, 2023
Previous fracture and subsequent fracture risk: a meta-analysis to update FRAXJ A Kanis, H Johansson, E V McCloskey, et al.
Pageof 42